PDCD1 and neoplasm: MCC demonstrates immune escape by upregulating PD-1 in tumor infiltrating and peripheral blood MCPyV-specific T cells [8], which negatively modulates immune function in response to intratumoral expression of its major ligand, PD-L1 [9, 10].